NR1H4 and metabolic dysfunction-associated steatotic liver disease: The results of Chang Yeob Han et al. showed that, in patients with NAFLD and mice with liver injury, the level of FXR in the liver was negatively correlated with the activation of NLRP3 inflammasome, suggesting an inhibitory role of FXR on the NLRP3 inflammasome.